porfirin 2011

Upload: yuliana-latif

Post on 03-Apr-2018

226 views

Category:

Documents


0 download

TRANSCRIPT

  • 7/28/2019 PORFIRIN 2011

    1/30

    Porphyrins & Bile Pigments

    FY WIDODO

    University of Wijaya Kusuma Surabaya

    Medical Faculty

    Department of Biochemistry

  • 7/28/2019 PORFIRIN 2011

    2/30

    MEMBUAT RANGKUMAN KULIAH

    MANFAAT YANG BISA DIAMBIL DARI MATERIKULIAH INI (BERSIFAT KLINIS)

    MINIMUM 3 HALAMAN FOLIO, MAKSIMUM 5HALAMAN FOLIO UNTUK 2 MATA KULIAH, PORFIRINDAN PURIN/PIRIMIDIN

    TULISAN TANGAN !!!

    TULIS NAMA, NPM, MATERI KULIAH, NAMA DOSEN

    DISERAHKAN PALING LAMBAT 1 MINGGU SETELAHSELESAI KULIAH PORFIRIN/PURIN / PIRIMIDIN

    TUGAS KULIAH

    PORFIRIN/PURIN/PIRIMIDIN

  • 7/28/2019 PORFIRIN 2011

    3/30

    PORFIRIN Cyclic compounds formed by the linkage

    of four pyrrole rings through methyne (HC =) bridges

    Formation of complexes with metal ions

    bound to the nitrogen atom of the pyrrole

    rings

    Examples of Some Important Human Hemoproteins

    Protein Function

    Hemoglobin Transport of oxygen in blood

    Myoglobin Storage of oxygen in muscle

    Cytochrome c Involvement in electron transportchain

    Cytochrome P450 Hydroxylation of xenobiotics

    Catalase Degradation of hydrogen peroxide

    Tryptophan

    pyrrolase Oxidation of tryptophan

  • 7/28/2019 PORFIRIN 2011

    4/30

    A (acetate)P (propionate)

    M (methyl)

    Addition of iron to protoporphyrin

    to form heme. V (vinyl) = CHCH2.

  • 7/28/2019 PORFIRIN 2011

    5/30

    Formation of Heme

    The two starting materials are succinyl-CoA and glycine

    Pyridoxal phosphate "activate" glycine Condensation reaction between succinyl-CoA and glycine a-amino-

    b-ketoadipic acid d-aminolevulinate (ALA)

    Enzyme: ALA synthase

    decarboxilation

    MITOCHONDRIA

    Two molecules of ALA are condensed by the enzymeALA

    dehydratase to form two molecules of water and one of

    porphobilinogen (PBG)ALA dehydratase is a zinc-containing enzyme and is

    sensitive to inhibition by lead, as can occur in lead

    poisoning.CYTOSOL

  • 7/28/2019 PORFIRIN 2011

    6/30

  • 7/28/2019 PORFIRIN 2011

    7/30

    The formation of a cyclic tetrapyrroleie, a porphyrinoccurs by

    condensation of four molecules of PBG

    These four molecules condense in a head-to-tail manner to form alinear tetrapyrrole, hydroxymethylbilane (HMB)

    Enzyme: uroporphyrinogen I synthase = porphobilinogen(PBG)deaminase = HMB synthase

    cyclizes spontaneously uroporphyrinogen I HMB

    uroporphyrinogen III synthase uroporphyrinogen III

    These compounds are colorless (porphyrinogens) auto-oxidizedporphyrins (colored).

  • 7/28/2019 PORFIRIN 2011

    8/30

  • 7/28/2019 PORFIRIN 2011

    9/30

    uroporphyrinogen Iuroporphyrinogen decarboxylase

    coproporphyrinogen I

    uroporphyrinogen III coproporphyrinogen III

    Acetate (A) methyle (M) : decarboxylated by

    uroporphyrinogen decarboxylase

    coproporphyrinogen III

    coproporphyrinogen oxidaseprotoporphyrinogen III

    protoporphyrinogen IIIprotoporphyrinogen oxidase

    protoporphyrin III

    Requires molecular oxygen. Protoporphyrin III + Fe2+Heme

    Enzyme: ferrochelatase (heme synthase)

    cytosol

    mitochondria

  • 7/28/2019 PORFIRIN 2011

    10/30

    Decarboxylation of uroporphyrinogens to coproporphyrinogens in

    cytosol. (A, acetyl; M, methyl; P, propionyl.)

    Heme biosynthesis occurs in most mammalian cells with the exception of

    mature erythrocytes, which do not contain mitochondria.

    However, approximately 85% of heme synthesis occurs in erythroid

    precursor cellsin the bone marrow and the majority of the remainder in

    hepatocytes.

  • 7/28/2019 PORFIRIN 2011

    11/30

  • 7/28/2019 PORFIRIN 2011

    12/30

    Regulation in Biosynthesis of Heme

    ALA synthase occurs in both hepatic (ALAS1) and erythroid (ALAS2)

    forms The rate-limiting enzyme:ALAS1feedback inhibition

    Heme (-) ALAS1 Heme (+)ALAS1

    Aporepressor molecule + Heme

    negative regulator of the synthesisof ALAS1

    Drugs (eg, barbiturates, griseofulvin) increase in ALAS1.

    Most of these drugs are metabolized by a system in the liver that

    utilizes cytochrome P450

    Glucose can prevent derepression of ALAS1 in liver as can the

    administration ofhematin (an oxidized form of heme).

  • 7/28/2019 PORFIRIN 2011

    13/30

  • 7/28/2019 PORFIRIN 2011

    14/30

    PORPHYRIAS

    Disorders due to abnormalities in the pathway of biosynthesis of

    heme genetic or acquired

  • 7/28/2019 PORFIRIN 2011

    15/30

    Enzyme Involved Type, Class, Major Signs and

    Symptoms

    Results of Laboratory

    Tests

    ALA synthase (erythroid

    form)

    X-linked sideroblastic

    anemia3 (erythro-poietic)

    Anemia Red cell counts and

    hemoglobin decreased

    ALA dehydratase ALA dehydratase defi-

    ciency (hepatic)

    Abdominal pain,

    neuropsychiatric

    symptoms

    Urinary ALA and

    coproporphyrin III

    increased

    Uroporphyrinogen I

    synthase

    Acute intermittent

    porphyria (hepatic)

    Abdominal pain,

    neuropsychiatric

    symptoms

    Urinary ALA and PBG

    increased

    Uroporphyrinogen IIIsynthase

    Congenital erythropoietic(erythropoietic)

    No photosensitivity Urinary, fecal, and red celluroporphyrin I increased

    Uroporphyrinogen

    decarboxylase

    Porphyria cutanea tarda

    (hepatic)

    Photosensitivity Urinary uroporphyrin I

    increased

    Coproporphyrinogen

    oxidase

    Hereditary

    coproporphyria (hepatic)

    Photosensitivity, abdo-

    minal pain, neuropsy-chiatric symptoms

    Urinary ALA, PBG, and

    coproporphyrin III and fecalcoproporphyrin III increase

    Protoporphyrinogen

    oxidase

    Variegate porphyria

    (hepatic)

    Photosensitivity, abdo-

    minal pain, neuropsy-

    chiatric symptoms

    Urinary ALA, PBG, and

    coproporphyrin III and fecal

    protoporphyrin IX increased

    Protoporphyrinogen

    oxidase

    Variegate porphyria

    (hepatic) (MIM 176200)

    Photosensitivity, abdo-

    minal pain, neuropsy-chiatric symptoms

    Urinary ALA, PBG, and

    coproporphyrin III and fecalprotoporphyrin IX increased

  • 7/28/2019 PORFIRIN 2011

    16/30

    In general, the porphyrias described are inherited in an autosomal

    dominant manner, with the exception of congenital erythropoietic

    porphyria, which is inherited in a recessive mode

    The signs and symptoms of porphyria result from either a deficiency of

    metabolic products beyond the enzymatic block or from an

    accumulation of metabolites behind the block.

    If the enzyme lesion occurs early in the pathway, clinically, patients

    complain ofabdominal pain and neuropsychiatric symptoms relate

    to elevated levels of ALA or PBG or to a deficiency of heme

    If the enzyme blocks laterin the pathway result in the accumulation of

    the porphyrinogens, their oxidation products, the corresponding

    porphyrin derivatives, cause photosensitivity, a reaction to visible light

    of about 400 nm The porphyrins, when exposed to light of this

    wavelength, are thought to become "excited" and then react with

    molecular oxygen to form oxygen radicalsinjure lysosomes and

    other organelles release their degradative enzymesskin

    damage, including scarring.

    The porphyrias can be classified on the basis of the organs or cells

    that are most affected: erythropoietic, hepatic & erythrohepatic

  • 7/28/2019 PORFIRIN 2011

    17/30

    Barbiturates, griseofulvin cytochrome P450 heme ALAS1

    porphyria

    Diagnosis: clinical and family history, the physical examination, and

    appropriate laboratory tests

    Treatment: - symptomatic

    - to avoid drugs that cause induction of cytochrome P450.

    - glucose,hematin may repress ALAS1

    - photosensitivity : b-carotene free radicals

    Sunscreens

  • 7/28/2019 PORFIRIN 2011

    18/30

    Katabolisme Heme 12 x 108 erythrocytes are destroyed per hour in 1 day turns over

    approximately 6 g of hemoglobin

    globin amino acids reused; ironpool Enzyme: complex enzyme system called heme oxygenase

    METABOLISME BILIRUBINPENGAMBILAN BILIRUBIN OLEH HATI

    Bilirubin hanya sedikit larut dalam plasma & terikat dengan albumin

    Obat / antibiotika kompetisi untuk berikatan dg albumin

    LIVER: Bilirubin dilepas dari albumin diambil pada permukaansinusoid hapatositSistem Transport Berfasilitas (facilitated transport

    system = carrier-mediated saturable system) masuk ke sel hati

    berikatan dengan cytosolic protein (ligandin, protein Y). Ikatan ini juga

    menjaga agar bilirubin tidak kembali ke aliran darah lagi.

    Aktivitas sistem ini menurun pada keadaan patologis

  • 7/28/2019 PORFIRIN 2011

    19/30

    hijau

    kuning

  • 7/28/2019 PORFIRIN 2011

    20/30

    KONJUGASI BILIRUBIN

    LIVER: Bilirubin yang non-polar polar

    Konjugasi dengan GLUKORONATBilirubin diglukoronida(conjugated, "direct-reacting" bilirubin) polar

    Enzyme: glucuronosyltransferase(dlm retikulum endoplasma) Donor glukuronosil: UDP-glucuronic acid

    Enzim dapat diinduksi oleh Phenobarbital Bilirubin diglukoronida diekskresi melalui faeces

    when exist abnormally in human plasma (eg, in obstructive jaundice),

    they are predominantly monoglucuronides

    Obstructive jaundice bilirubin conjugates (predominan

    monoglukuronida)

    Bilirubin diglukoronida

  • 7/28/2019 PORFIRIN 2011

    21/30

    METABOLISME BILIRUBIN DALAM USUSDiglukoronida

    Bilirubindiglukoronida Bilirubin

    Bilirubin direduksi oleh flora ususUROBILINOGEN (tak berwarna)

    Sebagian kecil urobilinogen diabsorbsi & diresekresi melalui liver (SIKLUS

    ENTEROHEPATIK)

    Sebagian besar urobilinogen oksidasiUROBILIN (kuning) faeces

    Urobilinogen dlm urine

    abnormal

    b-glukoronidase Bakteri usus

  • 7/28/2019 PORFIRIN 2011

    22/30

    Diagrammatic representation of the threemajor processes (uptake, conjugation,

    and secretion) involved in the transfer of

    bilirubin from blood to bile. Certain proteins

    of hepatocytes, such as ligandin (a member

    of the glutathione S-transferase family of

    enzymes) and Y protein, bind intracellular

    bilirubin and may prevent its efflux into the

    blood stream. The process affected in a

    number of conditions causing jaundice

    is also shown.

  • 7/28/2019 PORFIRIN 2011

    23/30

    HIPERBILIRUBINEMIA

    Bilirubin dlm darah >1 mg/dl.

    Penyebab: - produksi bilirubin h tidak sebanding dg ekskresi hati- kegagalan ekskresi hati karena:

    - kerusakan hati

    - obstruksi saluran ekskresi

    Bilirubin masuk ke jaringan

    Ehrlichs test dari van den Bergh:

    - reagen diazo + Bilirubin + etanol senyawa Azo (ungu-merah)

    INDIRECT REACTION BILI UNCONJUGATED (FREE)- reagen diazo + Bilirubin (tanpa etanol) senyawa Azo

    DIRECT REACTION BILI CONJUGATED Retention hyperbilirubinemia: unconjugated hh

    Regurgitation hyperbilirubinemia : conjugated hh

    Bili unconjugated dpt menembus blood-brain barrier encephalopathy

    Kern icterus

    KUNING / ICTERUS / JAUNDICE

  • 7/28/2019 PORFIRIN 2011

    24/30

    Jaundice

  • 7/28/2019 PORFIRIN 2011

    25/30

    UNCONJUGATED HYPERBILIRUBINEMIA

    A. Hemolytic Anemias

    Biasanya ringan (< 4 mg/dL; < 68.4 mmol/L) kapasitas hati besar

    utk mengelola bilirubin (uptake, konjugasi, ekskresi)

    B. Neonatal Physiologic Jaundice

    - Hemolisis > metabolisme bilirubin dlm hati- aktivitas / sintesis UDP-glukoronosil transferase K

    - Dpt menyebabkan Kern icterus

    - Tx: Phenobarbital +

    http://upload.wikimedia.org/wikipedia/en/d/d9/Jaundice_phototherapy.jpg
  • 7/28/2019 PORFIRIN 2011

    26/30

    C.Crigler-Najjar Syndrome, Type I

    - = Congenital nonhemolytic jaundice

    - Autosomal resesif; mutasi pada gen pengkode enzim Bilirubin-

    UGT UDP-glukoronosil transferase K- Bilirubin bisa sd > 20 mg/dL bilirubin tdk bisa dikonjugasikan

    - Klinis: ikterus kongenital berat fatal dalam 15 bulan

    - Tx: , liver transplant. Phenobarbital tdk menolong.

    D. Crigler-Najjar Syndrome, Type II- Mutasi pada gen pengkode enzim Bilirubin-UGT, tdk seberat

    tipe I, bilirubin serum tdk sampai 20 mg/dL

    - Dapat di Tx dg Phenobarbital dosisi tinggi

    E. Gilbert Syndrome

    - Mutasi pada gen pengkode enzim Bilirubin-UGT, sering pada pria

    - Klinis tdk berat, aktivitas enzim masih ada sekitar 30 %

    F. Toxic Hyperbilirubinemia

    - chloroform, arsphenamine, CCl4, acetaminophen, virus hepatitis,

    chirrhosis, jamur beracun kerusakan parenkim hati

  • 7/28/2019 PORFIRIN 2011

    27/30

    CONJUGATED HYPERBILIRUBINEMIA

    A. OBSTRUKSI SALURAN EMPEDU

    - Penyebab: baru empedu, ca. caput pankreas.- Bilirubin diglukoronida tidak bisa diekskresi regurgitasi ke vena-

    vena di liver dan saluran limfe bilirubin masuk ke aliran darah dan

    urine (choluric jaundice)

    - Cholestatic Jaundice: extrhepatic obstructive jaundice

    B. DUBIN-JOHNSON SYNDROME

    - Autosomal resesif, mutasi gen MRP-2

    - Hepatosit pada area centrilobular mengandung pigmen hitam yang

    abnormal yang merupakan derivat epinephrine.

    C. ROTOR SYNDROME

    - Hiperbilirubinemia terkonjugasi yang kronis, histopatologi hepar tetap

    normal

    - Etiologi: tdk tahu

  • 7/28/2019 PORFIRIN 2011

    28/30

    Diagrammatic representation of some major causes of jaundice

    Prehepatic indicates events in

    the blood stream, the majorcause would be various forms

    of hemolytic anemia

    Hepatic signifies events in the

    liver, such as the various types

    of hepatitis or other forms ofliver disease (eg. cancer)

    Posthepatic refers to evens in

    the billiary tree, the major

    causes of posthepatic jaundice

    are obstruction of the commonbile duct by a gallstone (billiary

    calculus) or bya cancer of the

    head of pancreas

  • 7/28/2019 PORFIRIN 2011

    29/30

    Condition Serum Bilirubin Urine

    Urobilinogen

    Urine

    Bilirubin

    Fecal

    Urobilinogen

    Normal Direct: 0.10.4

    mg/dL

    Indirect: 0.20.7mg/dL

    04 mg/24 h Absent 40280 mg/24 h

    Hemolytic

    anemia

    Indirect h Increased Absent Increased

    Hepatitis Direct and

    indirect h

    Decreased if

    micro-obstruction is

    present

    Present if

    micro-obstruction

    occurs

    Decreased

    Obstructive

    jaundice

    Direct h Absent Present Trace to absent

    Laboratory Results in Normal Patients and Patients with Three

    Different Causes of Jaundice

  • 7/28/2019 PORFIRIN 2011

    30/30